Natco Pharma Ltd Share Price – NSE  / BSE

Pharmaceuticals, Small Cap

Natco Pharma will hold a meeting of the Board of Directors of the Company on 28 May 2025.

Powered by Capital Market - Live News

Natco Pharma today updates on the legal proceedings on Risdiplam launch in India.

The Company has received numerous enquiries from investors and patients about the launch, availability and pricing of generic version of Risdiplam in the Indian market. The Company wishes to clarify that the Ld. Single Judge of Delhi High Court had through order dated 24 March 2025 denied Roche's plea for an injunction against the Company for the drug. However, Roche has appealed the decision before the Appellate Bench of the Delhi High Court who has currently directed to maintain the status quo. Due to pendency of the proceedings before the court, the Company does not wish to comment on the status of the proceedings. However, it has been the stand of the Company that it intends to launch the drug only after and subject to successful clarity from the Appellate Bench of the Delhi High Court which is expected shortly.

Subject to the foregoing, the Company has decided to price the product at Rs 15,900 MRP consistent with the Company's stand before the court. The Company also intends to offer discount to certain deserving patients through its patient access programme.

Powered by Capital Market - Live News

Natco Pharma Ltd is up for a fifth straight session in a row. The stock is quoting at Rs 823.5, up 0.06% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is up around 0.14% on the day, quoting at 22577. The Sensex is at 74336.54, down 0%. Natco Pharma Ltd has dropped around 35.76% in last one month.

Meanwhile, Nifty Pharma index of which Natco Pharma Ltd is a constituent, has dropped around 5.72% in last one month and is currently quoting at 20423.35, up 0.02% on the day. The volume in the stock stood at 3.53 lakh shares today, compared to the daily average of 19.39 lakh shares in last one month.

The PE of the stock is 8.31 based on TTM earnings ending December 24.

Powered by Capital Market - Live News

Natco Pharma Ltd gained for a third straight session today. The stock is quoting at Rs 837, up 1.69% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 0.08% on the day, quoting at 22571.15. The Sensex is at 74623.15, up 0.23%. Natco Pharma Ltd has dropped around 28.81% in last one month.

Meanwhile, Nifty Pharma index of which Natco Pharma Ltd is a constituent, has dropped around 4.72% in last one month and is currently quoting at 20389.7, down 0.5% on the day. The volume in the stock stood at 6.37 lakh shares today, compared to the daily average of 15.09 lakh shares in last one month.

The PE of the stock is 8.31 based on TTM earnings ending December 24.

Powered by Capital Market - Live News